¼ø»Æʦapp's Stiles-Nicholson Brain Institute Hosts 'Brainy Days' Celebration
¼ø»Æʦapp's Stiles-Nicholson Brain Institute will celebrate advancements in brain science and health with its annual "Brainy Days" events throughout the month of March.
Fluorescent Probes Illuminate Cholesterol and Alzheimer's Research
¼ø»Æʦapp researchers have developed cutting-edge fluorescent cholesterol probes, which now enable them to visualize cholesterol movement and distribution in live cells with unprecedented detail.
'Ding-Dong:' A Study Finds Specific Neurons With an Immune Doorbell
¼ø»Æʦapp neuroscientists have identified that the receptor IL-1R1 plays a critical role in enabling neurons to directly communicate with the immune system.
¼ø»Æʦapp's Randy D. Blakely, Ph.D., Honored as a Prestigious ASPET Fellow
Randy D. Blakely, Ph.D., a highly regarded neuroscientist and pharmacologist, is among an extraordinary group selected by the American Society for Pharmacology and Experimental Therapeutics.
¼ø»Æʦapp Adds State-of-the-Art MRI System to Advance Research Capabilities
¼ø»Æʦapp has added a new state-of-the-art MRI system to its research infrastructure, marking a transformative step forward for groundbreaking studies in neuroscience, clinical health and medical advancements.
Master Copper Regulator Discovery May Offer Alzheimer's Clues
A groundbreaking study by ¼ø»Æʦapp researchers using a tiny roundworm, links the worm gene swip-10 to copper regulation, which could pave the way for new treatments for neurodegenerative disorders.
¼ø»Æʦapp Ranks Among 'Washington Monthly' Top Public, Private Universities
¼ø»Æʦapp has been ranked No. 41 overall among the nation's best public and private universities by Washington Monthly.
A 'One in a Million' Shot to Tackle Dopamine-Linked Brain Disorders
With the help of a tiny, transparent worm, ¼ø»Æʦapp researchers have identified novel players in dopamine signaling by taking advantage of a powerful platform generated via the Million Mutation Project (MMP).
'Fit2Drive' Transforms Assessing Older Drivers with Cognitive Decline
"Fit2Drive," an algorithm developed by ¼ø»Æʦapp researchers has made it easy to administer and evaluate an in-office test to predict an older individual's probability of passing an on-road driving test.
¼ø»Æʦapp Hosts Inaugural Amyloid Related Diseases Summit
The summit brought together leading scientists in the field across North America and Europe to discuss the latest research and advancements in the study of amyloid-related diseases.